Results 201 to 210 of about 22,001 (226)

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

Lancet, The, 2023
exaly  

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

Lancet, The, 2018
Zhi-wei Lai, Stephen Faraone, Andras Perl   +2 more
exaly  

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)

Lancet, The, 2023
exaly  

B cell depletion therapies in autoimmune disease: advances and mechanistic insights

Nature Reviews Drug Discovery, 2020
Olga L Rojas, Jennifer L Gommerman
exaly  

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease

Nature Medicine, 2016
Christian Lood, Luz P Blanco, Carmelo Carmona-Rivera   +2 more
exaly  

Lupus anticoagulants.

Progress in hemostasis and thrombosis, 1983
S S, Shapiro, P, Thiagarajan
openaire   +1 more source

Lupus anticoagulant and pregnancy

American Journal of Obstetrics and Gynecology, 1986
B, Spitz, F A, Van Assche, J, Vermylen
openaire   +2 more sources

Systemic lupus erythematosus

Lancet, The, 2007
Munther A Khamashta
exaly  

[Lupus anticoagulant].

Harefuah, 1986
A, Kornberg, S, Kaufman
openaire   +1 more source

Lupus Anticoagulant-Hypoprothrombinemia Syndrome

The Indian Journal of Pediatrics, 2017
Rohit Bhowmick, Indira Agarwal, Venkatesh Arumugam, Sathish Kumar T   +3 more
openaire   +2 more sources